Sharon Lamb
Sharon Lamb focuses her practice on transactional and regulatory advice in the health and life sciences sector.
Sharon advises on global transactional mandates, including mergers and acquisitions and joint ventures in health services, pharma and life sciences, digital health and health data technologies.
Damages Are Adequate – But Is It Sufficiently Serious?
By Sharon Lamb and Kimberley Smith on Mar 21, 2024
Posted In Healthcare, United Kingdom
In a highly-anticipated judgment dated January 30, 2024, the Court of Appeal confirmed that in a procurement challenge under the Public Contract Regulations 2015 (PCR), a finding of a manifest error will not automatically mean that the error is ‘sufficiently serious’ to justify an award of damages. This blog piece is a reduced version of...
Continue Reading
